Pharvaris N.V. - Ordinary Shares, par value Euro 0.12 per share (PHVS)
CUSIP: N69605108
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Ordinary Shares, par value Euro 0.12 per share
- Shares outstanding
- 65,237,679
- Total 13F shares
- 21,647,018
- Share change
- +15,380
- Total reported value
- $321,068,000
- Price per share
- $14.39
- Number of holders
- 22
- Value change
- -$1,695,268
- Number of buys
- 7
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP N69605108?
CUSIP N69605108 identifies PHVS - Pharvaris N.V. - Ordinary Shares, par value Euro 0.12 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP N69605108:
Top shareholders of PHVS - Pharvaris N.V. - Ordinary Shares, par value Euro 0.12 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Foresite Capital Management IV, LLC |
13F
|
Company |
5%
|
3,261,926
|
$57,834,000 | — | 30 Sep 2021 | |
| FMR LLC |
13F
|
Company |
5.1%
|
3,312,859
|
$57,146,000 | — | 30 Sep 2021 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
4.9%
|
3,180,601
|
$56,392,000 | — | 30 Sep 2021 | |
| GENERAL ATLANTIC, L.P. |
13F
|
Individual |
3.7%
|
2,420,155
|
$42,909,000 | — | 30 Sep 2021 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
3.7%
|
2,391,517
|
$41,254,000 | — | 30 Sep 2021 | |
| venBio Partners LLC |
13F
|
Company |
3.5%
|
2,303,310
|
$40,838,000 | — | 30 Sep 2021 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
2.5%
|
1,608,471
|
$28,518,000 | — | 30 Sep 2021 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1.1%
|
689,731
|
$12,229,000 | — | 30 Sep 2021 | |
| VR Adviser, LLC |
13F
|
Company |
0.85%
|
552,882
|
$9,803,000 | — | 30 Sep 2021 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
0.85%
|
557,059
|
$9,609,000 | — | 30 Sep 2021 | |
| Novo Holdings A/S |
13F
|
Company |
0.64%
|
418,943
|
$7,428,000 | — | 30 Sep 2021 | |
| Foresite Capital Management V, LLC |
13F
|
Company |
0.56%
|
364,142
|
$6,456,000 | — | 30 Sep 2021 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.38%
|
244,925
|
$4,225,000 | — | 30 Sep 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.24%
|
157,753
|
$2,721,000 | — | 30 Sep 2021 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.05%
|
35,074
|
$622,000 | — | 30 Sep 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.05%
|
30,174
|
$535,000 | — | 30 Sep 2021 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.04%
|
27,000
|
$479,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
18,643
|
$321,000 | — | 30 Sep 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
17,547
|
$311,000 | — | 30 Sep 2021 | |
| Lombard Odier SCmA Compagnie |
13F
|
Individual |
0.03%
|
16,670
|
$287,000 | — | 30 Sep 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.02%
|
15,904
|
$274,000 | — | 30 Sep 2021 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.01%
|
5,000
|
$86,000 | — | 30 Sep 2021 | |
| UBS Group AG |
13F
|
Company |
0%
|
654
|
$12,000 | — | 30 Sep 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
500
|
$9,000 | — | 30 Sep 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
198
|
$4,000 | — | 30 Sep 2021 |
Institutional Holders of Pharvaris N.V. - Ordinary Shares, par value Euro 0.12 per share (PHVS) as of Q4 2021
As of 31 Dec 2021,
Pharvaris N.V. - Ordinary Shares, par value Euro 0.12 per share (PHVS) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,647,018 shares.
The largest 10 holders included
FMR LLC, Foresite Capital Management IV, LLC, Bain Capital Life Sciences Investors, LLC, VIKING GLOBAL INVESTORS LP, GENERAL ATLANTIC, L.P., venBio Partners LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), SUVRETTA CAPITAL MANAGEMENT, LLC, Cormorant Asset Management, LP, and PICTET ASSET MANAGEMENT SA.
This page lists
22
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
25
Q4 2021 holders
22
Holder diff
-3
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.